AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive-Réanimation, 94010, Créteil, France.
Université Paris Est Créteil, CARMAS, 94010, Créteil, France.
Intensive Care Med. 2022 May;48(5):517-534. doi: 10.1007/s00134-022-06640-1. Epub 2022 Mar 16.
Hypercapnia is frequent during mechanical ventilation for acute respiratory distress syndrome (ARDS), but its effects on morbidity and mortality are still controversial. We conducted a systematic review and meta-analysis to explore clinical consequences of acute hypercapnia in adult patients ventilated for ARDS.
We searched Medline, Embase, and the Cochrane Library via the OVID platform for studies published from 1946 to 2021. "Permissive hypercapnia" defined hypercapnia in studies where the group with hypercapnia was ventilated with a protective ventilation (PV) strategy (lower V targeting 6 ml/kg predicted body weight) while the group without hypercapnia was managed with a non-protective ventilation (NPV); "imposed hypercapnia" defined hypercapnia in studies where hypercapnic and non-hypercapnic patients were managed with a similar ventilation strategy.
Twenty-nine studies (10,101 patients) were included. Permissive hypercapnia, imposed hypercapnia under PV, and imposed hypercapnia under NPV were reported in 8, 21 and 1 study, respectively. Studies testing permissive hypercapnia reported lower mortality in hypercapnic patients receiving PV as compared to non-hypercapnic patients receiving NPV: OR = 0.26, 95% CI [0.07-0.89]. By contrast, studies reporting imposed hypercapnia under PV reported increased mortality in hypercapnic patients receiving PV as compared to non-hypercapnic patients also receiving PV: OR = 1.54, 95% CI [1.15-2.07]. There was a significant interaction between the mechanism of hypercapnia and the effect on mortality.
Clinical effects of hypercapnia are conflicting depending on its mechanism. Permissive hypercapnia was associated with improved mortality contrary to imposed hypercapnia under PV, suggesting a major role of PV strategy on the outcome.
在急性呼吸窘迫综合征(ARDS)机械通气期间常发生高碳酸血症,但它对发病率和死亡率的影响仍存在争议。我们进行了一项系统评价和荟萃分析,以探讨成人 ARDS 患者机械通气时急性高碳酸血症的临床后果。
我们通过 OVID 平台在 Medline、Embase 和 Cochrane 图书馆中搜索了 1946 年至 2021 年发表的研究。“允许性高碳酸血症”定义为高碳酸血症发生在高碳酸血症组接受保护性通气(PV)策略(低目标潮气量 6ml/kg 预测体重)而无高碳酸血症组接受非保护性通气(NPV)的研究中;“强制高碳酸血症”定义为高碳酸血症和非高碳酸血症患者接受类似通气策略的研究中发生的高碳酸血症。
共纳入 29 项研究(10101 例患者)。分别有 8、21 和 1 项研究报告了允许性高碳酸血症、PV 下的强制高碳酸血症和 NPV 下的强制高碳酸血症。接受 PV 的高碳酸血症患者与接受 NPV 的非高碳酸血症患者相比,接受 PV 的允许性高碳酸血症患者的死亡率较低:OR=0.26,95%CI [0.07-0.89]。相比之下,报告 PV 下强制高碳酸血症的研究报告称,接受 PV 的高碳酸血症患者的死亡率高于接受 PV 的非高碳酸血症患者:OR=1.54,95%CI [1.15-2.07]。高碳酸血症的发生机制与死亡率的影响之间存在显著的交互作用。
高碳酸血症的临床影响因发生机制而异。与 PV 下的强制高碳酸血症相反,允许性高碳酸血症与死亡率的降低有关,这表明 PV 策略对结果有重要影响。